Human Fetus at 23 Weeks in the Womb (Asian Skin)

Description

A fetus at approximately 23 weeks of gestation lies in a flexed attitude within the intact amniotic sac, seen in profile from the left side. The head is disproportionately large relative to the trunk, with a smooth prominent forehead, closed fused eyelids beginning to separate, a well-modelled auricle standing away from the scalp, and a slightly open mouth. The upper limbs are drawn toward the chest with the fingers of both hands touching, while the lower limbs cross at the ankles in the classic fetal posture. The umbilical cord emerges from the abdomen and spirals toward the chorionic plate of the placenta, whose vascular surface is visible through the translucent membranes; the endometrium and thickened uterine wall enclose the amniotic fluid space, and the skin is thin, wrinkled and vascular with vernix-poor translucency typical of this stage. The twenty-third week sits at the threshold of extrauterine viability, when pulmonary development advances from the canalicular into the saccular phase and surfactant production begins in earnest, making gestational dating and growth assessment clinically decisive. Views of this kind support discussion of anomaly and growth ultrasound findings, amniotic fluid volume, cord insertion and placental location, and counselling around threatened preterm birth, antenatal corticosteroids and neonatal intensive care thresholds. Fetal position, cord coiling and membrane integrity shown here are the same parameters assessed sonographically in routine second-trimester surveillance. The rendering suits obstetric and midwifery teaching sequences that track week-by-week development, antenatal clinic and childbirth-education material for expectant parents, and figures for textbooks, apps and public health publications on fetal growth and prematurity. Perinatologists, sonographers, neonatal nurses and health communicators can use it alongside the companion weeks in the series to convey continuity of development. Anatomical accuracy verified by SciePro's Medical Advisory Board.